Phlegmonous gastritis developed during chemotherapy for acute lymphocytic leukemia: A case report

Table 2 Clinical features of phlegmonous gastritis after chemotherapy for hematological malignancy

No.	Ref.	Age	Sex	Hematological malignancy	WBC/neutrophils	Pathogen(s)	Histopathological examination	Gastric acid secretion inhibitor	Outcome
1	Takeuchi et al[10]	63	M	ATLL	300/unknown	Gram-positive cocci and Gram-negative bacilli1	Not executed	H2-RA	Death
2	Matsumoto et al[11]	74	M	MF and MM	800/300	Bacillus thuringiensis	Not executed	Unknown	Death
3	Iqbal et al[12]	59	F	AML (2nd relapse)	< 100/0	Citrobacter freundii/Enterococcus faecalis/Bacillus cereus	Not executed	Unknown	Recovered
4	Inagawa et al[13]	34	F	APL with MF	320/20	Enterobacter cloacae/Enterococcus species/MRS	Not executed	PPI	Death
5	Shi et al[14]	33	M	MPAL	70/unknown	Stenotrophomonas maltophilia	Not executed	PPI	Recovered
6	Saito et al[9]	55	F	ALL	100/4	Bacillus cereus	Executed	PPI	Recovered
7 (this case)		70	F	ALL	100/98	Bacillus cereus	Executed	P-CAB	Recovered

¹Colonies were confirmed, but bacterial species could not be identified. ATLL: Adult T-cell leukemia/lymphoma; MF: Myelofibrosis; MM: Multiple myeloma; AML: Acute myeloid leukemia; APL: Acute promyelocytic leukemia; MPAL: Mixed-phenotype acute leukemia; ALL: Acute lymphocytic leukemia; WBC: White blood cells; MRS: Methicillin-resistant Staphylococcus; H₂-RA: Histamine H₂-receptor antagonist, PPI: Proton pump inhibitor; P-CAB: Potassium-competitive acid blocker; M: Male; F: Female.